Michael Banitt
September 25, 2020
Adding Ampho B to the medium is just one more way I know CorneaGen has the patient’s best interest in mind.
Recent Articles
-
Bernie’s Quarterly Update – July 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...
READ MORE -
Photo: Bernie Iliakis hosts a lively conversation at ASCRS Boston with
Edward J. Holland M.D. and Terry Kim M.D.
Bernie’s Quarterly Update – April 2024A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE